Roy M Gulick Selected Research

Integrases

12/2021	Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
1/2018	ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy M Gulick Research Topics

Disease

37	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 07/2002
19	Infections 01/2019 - 01/2002
16	HIV Infections (HIV Infection) 01/2022 - 01/2002
4	COVID-19 10/2022 - 01/2020
4	Viremia 01/2019 - 11/2003
3	Disease Progression 05/2011 - 03/2007
2	Hepatitis B 01/2018 - 12/2005
2	Insulin Resistance 05/2011 - 04/2007
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2006 - 01/2002
1	Coronavirus Infections 10/2022
1	Injection Site Reaction 12/2021
1	Thrombosis (Thrombus) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Diarrhea 01/2020
1	Vomiting 01/2020
1	Aspergillosis 09/2016
1	Sinusitis 09/2016
1	Hepatitis C 12/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2011
1	Virus Diseases (Viral Diseases) 12/2010
1	Tuberculosis (Tuberculoses) 07/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2010
1	Proteinuria 08/2009
1	Epstein-Barr Virus Infections 03/2009
1	Lymphoma (Lymphomas) 03/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009
1	Hodgkin Disease (Hodgkin's Disease) 03/2009
1	Neoplasms (Cancer) 07/2007
1	Lipodystrophy 12/2005
1	Hepatitis 12/2005
1	Fatty Liver 12/2005

Drug/Important Bio-Agent (IBA)

19	efavirenz (Sustiva)FDA Link 01/2018 - 04/2004
10	RNA (Ribonucleic Acid)IBA 01/2019 - 08/2006
7	Maraviroc FDA Link 01/2022 - 10/2008
7	NucleosidesIBA 01/2020 - 07/2002
7	Lamivudine (Epivir)FDA Link 01/2019 - 07/2002
6	abacavir (Ziagen)FDA Link 02/2015 - 04/2004
6	vicrivirocIBA 08/2010 - 02/2007
5	Reverse Transcriptase InhibitorsIBA 01/2020 - 04/2004
4	Zidovudine (Retrovir)FDA LinkGeneric 04/2007 - 07/2002
3	Tenofovir (Viread)FDA Link 01/2022 - 02/2019
3	Emtricitabine (Emtriva)FDA Link 01/2022 - 02/2019
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 04/2004
3	dolutegravirIBA 01/2019 - 03/2016
3	AntibodiesIBA 11/2018 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2009
3	Saquinavir (Invirase)FDA Link 11/2005 - 09/2002
3	Indinavir (Crixivan)FDA Link 04/2004 - 09/2002
2	RacivirIBA 12/2021 - 01/2018
2	IntegrasesIBA 12/2021 - 01/2018
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2020
2	Raltegravir Potassium FDA Link 02/2019 - 04/2009
2	Ritonavir (Norvir)FDA Link 02/2019 - 04/2004
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 11/2018 - 06/2004
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 12/2012 - 09/2010
2	LipidsIBA 05/2011 - 04/2007
2	HDL CholesterolIBA 04/2007 - 12/2005
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 10/2022
1	cabotegravirIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	theasinensin AIBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Integrase InhibitorsIBA 01/2020
1	Atazanavir Sulfate (Reyataz)FDA Link 02/2019
1	Darunavir (Prezista)FDA Link 02/2019
1	Illicit Drugs (Recreational Drugs)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	fibrin fragment D (D-dimer)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	Polysaccharides (Glycans)IBA 02/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2016
1	Lopinavir FDA Link 11/2011
1	C-Reactive ProteinIBA 05/2011
1	Peptides (Polypeptides)IBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	Amino Acids FDA Link 12/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010
1	Cytochrome P-450 CYP3AIBA 09/2010
1	Nevirapine (Viramune)FDA Link 03/2010
1	CreatinineIBA 08/2009
1	AntigensIBA 03/2009
1	oxidized low density lipoproteinIBA 04/2007
1	LDL CholesterolIBA 04/2007
1	Glucose (Dextrose)FDA LinkGeneric 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	CholesterolIBA 04/2007
1	ChemokinesIBA 02/2007
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2005

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2002
6	Art Therapy 11/2018 - 06/2004
2	Salvage Therapy 09/2002 - 01/2002
1	Injections 12/2021
1	Immunotherapy 01/2015
1	Aftercare (After-Treatment) 02/2006